← Advanced Bronchoscopy

The Presence of Targetable Mutations in Non-Small Cell Lung Cancer with Malignant Pleural Disease Is Not Associated with Improved Survival


Malignant pleural effusions (MPE) in non-small cell lung cancer (NSCLC) are common and generally associated with a poor prognosis. Numerous studies have highlighted improved outcomes for NSCLC patients treated with targeted therapies, however these studies often utilize heterogenous populations of metastatic NSCLC. Our aim was to assess the overall survival of NSCLC patients with MPE and actionable biomarkers.
Read the full paper ↗

Keep reading

N opens the next one